Why the study?
PR interval prolongation has long been considered benign, particularly in nonstructural heart disease, leaving its effect on cardiovascular outcomes unclear in device-treated patients.
Does a prolonged PR interval increase the incidence of atrial fibrillation, heart failure hospitalization, or death in patients with implanted cardiac devices?
Does a prolonged PR interval increase the incidence of atrial fibrillation, heart failure hospitalization, or death in patients with implanted cardiac devices?
In patients with implanted cardiac devices, a prolonged PR interval (≥190 ms) is significantly associated with an increased risk of atrial fibrillation, heart failure hospitalization, and death.
Answers are grounded in this paper and cite their sources.
May flag higher-risk device patients for monitoring; leaves open causal role and need for prospective trials.
Background Prolongation of the PR interval has long been considered a benign condition, particularly in the setting of nonstructural heart disease. Objective The purpose of this study was to investigate the effect of PR interval on various well-adjudicated cardiovascular outcomes using a large real-world population data of patients with implanted dual-chamber permanent pacemakers or implantable cardioverter-defibrillators. Methods PR intervals were measured during remote transmissions in patients with implanted permanent pacemakers or implantable cardioverter-defibrillators. Study endpoints (time to the first occurrence of AF, heart failure hospitalization [HFH], or death) were obtained between January 2007 and June 2019 from the deidentified Optum de-identified Electronic Health Record dataset. Results A total of 25,752 patients (age 69.3 ± 13.9 years; 58% male) were evaluated. The average intrinsic PR interval was 185 ± 55 ms. In the subset of 16,730 patients with available long-term device diagnostic data, a total of 2555 (15.3%) individuals developed AF during 2.59 ± 2.18 years of follow-up. The incidence of AF was significantly higher (up to 30%) in patients with a longer PR interval (ie, PR interval ≥270 ms; P < .05). Time-to-event survival analysis and multivariable analysis showed that PR interval ≥190 ms was significantly associated with higher incidence of AF, HFH, or HFH or death when compared with shorter PR intervals ( P < .05 for all 3 parameters). Conclusion In a large real-world population of patients with implanted devices, PR interval prolongation was significantly associated with increased incidence of AF, HFH, or death.
No takes yet. Share an insight, caveat, or question.
Yarmohammadi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: